|
2020
|
Invention
|
Metal salts and uses thereof. The present invention relates to metal salts of 2-[3-[(3R)-3-[[2-ch... |
|
|
Invention
|
Methods of treating cancer. The invention features methods of treating cancer with β-GPA. The dis... |
|
|
Invention
|
Methods of treating cancer. RRR)-3-[[2-chloro-3- (trifluoromethyl)phenyl]methyl-(2,2-diphenylethy... |
|
|
Invention
|
High-affinity anti-mertk antibodies and uses thereof. The present disclosure provides antibodies ... |
|
2018
|
Invention
|
Polymorphs and uses thereof. The present invention relates to new polymorphs of LXRβ agonists whi... |
|
|
Invention
|
Anti-mertk agonistic antibody-drug conjugates and uses thereof. The present disclosure provides a... |
|
|
Invention
|
Methods for the treatment of cancer. The invention features methods of treating cancer with a com... |
|
|
Invention
|
Formulations with improved stability. Formulations containing pharmaceutically active compounds w... |
|
2017
|
Invention
|
Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses ... |
|
2016
|
Invention
|
Pharmaceutically acceptable salts of β-guanidinopropionic acid with improved properties and uses ... |
|
|
Invention
|
Pharmaceutically acceptable salts of beta-guanidinopropionic acid with improved properties and us... |
|
|
Invention
|
Inhibitors of creatine transport and uses thereof. This invention relates to compounds that inhib... |
|
2015
|
Invention
|
Treatment and diagnosis of cancer.
This invention features compounds that modulate the activity ... |
|
|
Invention
|
Treatment and diagnosis of cancer. This invention features compounds that modulate the activity o... |
|
|
Invention
|
Lxr agonists and uses thereof. This invention features compounds that modulate the activity of li... |
